Mylan NV

General

Total Cases108
Active Cases18
Patents--
TypeOperating Company
Elite Ratings
CAFC

Ratings

Experience
Grade
Trend
DCT
L5
D
PTAB
L5
A
CAFC
L5
A

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
03/08/23
ORDER VACATING RULINGS AND DISMISSING CASE. (I) the Memorandum Opinion and Order Following Bench Trial (ECF No. 606), dated November 9, 2022, is hereby VACATED; (2) the Judgment In A Civil Action (ECF No. 607), dated November 9, 2022, is hereby VACATED; (3) all claims and counterclaims asserted in this action related to U.S. Patent No. 10,166,247 are DISMISSED WITH PREJUDICE; (4) Defendants Motion for Bill of Costs (ECF No. 616) is denied as moot. Each party to bear its own costs and fees. Signed by District Judge John Preston Bailey on 3/8/2023. (hrc) (Entered: 03/08/2023)
03/08/23
ORDER VACATING RULINGS AND DISMISSING CASE. (I) the Memorandum Opinion and Order Following Bench Trial (ECF No. 606), dated November 9, 2022, is hereby VACATED; (2) the Judgment In A Civil Action (ECF No. 607), dated November 9, 2022, is hereby VACATED; (3) all claims and counterclaims asserted in this action related to U.S. Patent No. 10,166,247 are DISMISSED WITH PREJUDICE; (4) Defendants Motion for Bill of Costs (ECF No. 616) is denied as moot. Each party to bear its own costs and fees. Signed by District Judge John Preston Bailey on 3/8/2023. (hrc) (Entered: 03/08/2023)
03/08/23
ORDER VACATING RULINGS AND DISMISSING CASE. (I) the Memorandum Opinion and Order Following Bench Trial (ECF No. 606), dated November 9, 2022, is hereby VACATED; (2) the Judgment In A Civil Action (ECF No. 607), dated November 9, 2022, is hereby VACATED; (3) all claims and counterclaims asserted in this action related to U.S. Patent No. 10,166,247 are DISMISSED WITH PREJUDICE; (4) Defendants Motion for Bill of Costs (ECF No. 616) is denied as moot. Each party to bear its own costs and fees. Signed by District Judge John Preston Bailey on 3/8/2023. (hrc) (Entered: 03/08/2023)
03/07/23
MANDATE of USCA for the Federal Circuit as to 608 Notice of Appeal filed by AstraZeneca AB, Astrazeneca Pharmaceuticals LP. (dk) (Entered: 03/07/2023)
03/06/23
ORDER GRANTING INDICATIVE RULING. ORDERED that if the cases are remanded to this Court by the Court of Appeals for the Federal Circuit, this Court will grant a joint motion pursuant to Rule 60(b)(5) and (6) of the Federal Rules of Civil Procedure, will (1) vacate the Amended Final Judgment Order (ECF No. 240) in the 558 Patent Action; (2) enter the Stipulated Modified Amended Final Judgment Order (Ex. 2) in the 558 Patent Action; and (3) enter the Order Vacating Rulings and Dismissing Case (Ex. 3) in the 247 Patent Action. Signed by District Judge John Preston Bailey on 3/06/2023. (hrc) (Entered: 03/06/2023)
02/27/23
Joint MOTION For An Indicative Ruling to Effect Settlement Under Fed. R. Civ. P. 62.1(a) by AstraZeneca AB, Astrazeneca Pharmaceuticals LP. (Attachments: # 1 Brief in Support of Joint Motion Under Fed. R. Civ. P. 62.1(a) for an Indicative Ruling to Effect Settlement, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4)(Companion, James) (Entered: 02/27/2023)
01/17/23
ORDER GRANTING 620 MOTION FOR EXTENSION OF TIME. The Court GRANTS the motion and ORDERS that Plaintiffs shall have through and until March 17, 2023, to object to Defendants' bill of costs. Signed by District Judge John Preston Bailey on 1/17/2023. (dk) (Entered: 01/17/2023)
01/17/23
MOTION for Extension of Time to File Response/Reply as to 616 MOTION for Bill of Costs by AstraZeneca AB, Astrazeneca Pharmaceuticals LP. (Attachments: # 1 Proposed Order)(Law, Sandra) (Entered: 01/17/2023)
01/10/23
ORDER. The Motion (Docs. 617 ) is GRANTED. Signed by District Judge John Preston Bailey on 1/10/2023. (dk) (Entered: 01/10/2023)
01/09/23
MOTION for Bill of Costs by Kindeva Drug Delivery L.P., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit Ex. 1, # 2 Exhibit Ex. 1A, # 3 Exhibit Ex. 2, # 4 Exhibit Ex. 3, # 5 Exhibit Ex. 4, # 6 Exhibit Ex. 5)(Copland, Gordon) (Entered: 01/09/2023)